UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Csenge Advisory Group

Csenge Advisory Group trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,845 shares of the healthcare conglomerate’s stock after selling 1,409 shares during the quarter. Csenge Advisory Group’s holdings in UnitedHealth Group were worth $4,980,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Friedenthal Financial purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at approximately $51,000. Highline Wealth Partners LLC acquired a new position in UnitedHealth Group during the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $523.48 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average price of $523.11 and a 200 day moving average price of $563.18. The company has a market cap of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have commented on UNH shares. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.